Article preview from Medtech Insight - July/August 2008
Continuous glucose monitoring (CGM) is moving closer to becoming a staple of effective diabetes treatment. The three companies that produce CGM devices - Medtronic, DexCom, and Abbott Laboratories - are very active in demonstrating the value of this technology, but other companies are stepping up in the market. Meanwhile, the focus on CGM is having an effect on other products, including insulin pumps. Find out more...
Continue reading "Diabetes: CGM Goes Mainstream" »
Medical Devices Today has provided a roundup of the most recent device and diagnostics deals, mergers and alliances from July and August from Windhover Information and FDC Reports’ Strategic Transactions - The Device Deal Database. Our proprietary database is designed for medical technology professionals and investors that need to stay current on the latest industry alliances, financing, mergers & acquisitions and other strategic partnerships.
Continue reading "At-A-Glance: Device Deals, Alliances, Financing and Acquisitions - July/August 2008" »
Full article reprinted from PharmAsia News - August 20, 2008
MUMBAI - A few of the world's top stent makers are in discussions with German stent manufacturer Eurocor for joint distribution of its next-generation interventional cardiovascular stents in the U.S. Find out more...
Continue reading "Eurocor In Talks With Global Stent Makers For Joint Distribution Of Next-Generation Stents " »
Full article reprinted from "The Gray Sheet" - August 18, 2008
Just as Boston Scientific is beginning to emerge from the quality control cloud it has been living under for the past couple years, FDA revealed Aug. 14 that the firm has recalled its NexStent carotid artery stenting system. Find out more...
Continue reading "Boston Scientific Initiates Worldwide Recall of NexStent" »
Full brief reprinted from "The Gray Sheet" - August 18, 2008
Find out about CMS' newly proposed regulation to adopt ICD-10 diagnosis and procedure codes that would replace 30-year-old ICD-9, used by health care providers, payers and other stakeholders for billing, tracking and other purposes.
Continue reading "Here Comes ICD-10" »
Full article reprinted from "The Gray Sheet" - August 18, 2008
FDA's device center has seen a lot of jumping around this year, with more than 40 upper-level moves since January (see chart: "New Jobs Since January").
Continue reading "The CDRH Shuffle: Device Center Tweaks Management Personnel" »
Full article reprinted from "The Gray Sheet" - August 18, 2008
Find out what device industry advocates are saying about a new Massachusetts law that requires all device and drug companies doing business in the state to abide by a strict marketing code of conduct.
Continue reading "New Mass. Law Irks Industry, As Focus Shifts To Reg Implementation" »
Article preview from Start-Up - July 2008
Following the sale of Boston Scientific's venture portfolio, secondary buyers are positioning themselves as possible purchases of venture capital portfolios.
Continue reading "Saints or Saviors? Secondary Buyers Offer Exit for BSX, Others " »